Company Quick10K Filing
Transmedics
10-Q 2021-03-31 Filed 2021-05-07
10-K 2020-12-31 Filed 2021-03-11
10-Q 2020-09-30 Filed 2020-11-06
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-06
10-K 2019-12-28 Filed 2020-03-17
10-Q 2019-09-28 Filed 2019-11-08
10-Q 2019-06-29 Filed 2019-08-08
S-1 2019-04-05 Public Filing
10-Q 2019-03-30 Filed 2019-06-12
8-K 2020-11-04
8-K 2020-08-05
8-K 2020-06-04
8-K 2020-06-02
8-K 2020-06-01
8-K 2020-05-26
8-K 2020-05-26
8-K 2020-05-06
8-K 2020-04-27
8-K 2020-04-20
8-K 2020-04-10
8-K 2020-03-02
8-K 2020-02-27
8-K 2020-01-13
8-K 2020-01-09
8-K 2019-11-06
8-K 2019-08-07
8-K 2019-06-11
8-K 2019-06-03
8-K 2019-05-01

Transmedics Financials

TMDX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2019-03-302019-06-292019-09-28
Cash12,71596,20088,300
Accounts Receivable5,1467,1056,465
Inventory11,29411,22010,536
PP&E3,7504,3754,746
Assets38,759121,014112,618
Accounts Payable5,4996,6624,766
Long-Term Debt35,00035,00035,000
Liabilities51,27849,85349,146
Stockholders' Equity-199,03871,16163,472
Income Statement ($'000)2019-03-302019-06-292019-09-28
Revenue5,2906,2157,876
Cost of Revenue2,1032,3332,989
Gross Profit2,5733,3334,216
R&D3,8824,7874,939
SG&A4,6536,2516,519
Tax
Net Income-6,895-9,195-8,280
Cash Flow ($'000)2019-03-302019-06-292019-09-28
Cash Operating-7,266-12,159-5,597
Cash Investing-3-49,093-18,765
Cash Financing-69796,094-2,428